Crossmark

Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study

Published Online: 2022-07-31

Published Print: 2022-12

Authors

Nirogi, Ramakrishna

Goyal, Vinod Kumar

Benade, Vijay

Subramanian, Ramkumar

Ravula, Jyothsna

Jetta, Satish

Shinde, Anil

Pandey, Santosh Kumar

Jayarajan, Pradeep

Jasti, Venkat

Cummings, Jeffrey https://orcid.org/0000-0001-8944-4158
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02580305 at ClinicalTrials.gov

Documents that mention this clinical trial

Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study
https://doi.org/10.1007/s40120-022-00390-4
Funding

Funding for this research was provided by:

National Institute of General Medical Sciences (P20GM109025)

National Institute of Neurological Disorders and Stroke (U01NS093334)

National Institute on Aging (R01AG053798)

National Institute on Aging (P20AG068053)

National Institute on Aging (P30AG072959)

National Institute on Aging (R35AG71476)
License Information

Text and Data Mining valid from 2022-07-31

Version of Record valid from 2022-07-31
More Information

Article History

Received: 16 June 2022

Accepted: 18 July 2022

First Online: 31 July 2022

Document is current